Differential overexpression of SERPINA3 in human prion diseases
- PMID: 29142239
- PMCID: PMC5688139
- DOI: 10.1038/s41598-017-15778-8
Differential overexpression of SERPINA3 in human prion diseases
Abstract
Prion diseases are fatal neurodegenerative disorders with sporadic, genetic or acquired etiologies. The molecular alterations leading to the onset and the spreading of these diseases are still unknown. In a previous work we identified a five-gene signature able to distinguish intracranially BSE-infected macaques from healthy ones, with SERPINA3 showing the most prominent dysregulation. We analyzed 128 suitable frontal cortex samples, from prion-affected patients (variant Creutzfeldt-Jakob disease (vCJD) n = 20, iatrogenic CJD (iCJD) n = 11, sporadic CJD (sCJD) n = 23, familial CJD (gCJD) n = 17, fatal familial insomnia (FFI) n = 9, Gerstmann-Sträussler-Scheinker syndrome (GSS)) n = 4), patients with Alzheimer disease (AD, n = 14) and age-matched controls (n = 30). Real Time-quantitative PCR was performed for SERPINA3 transcript, and ACTB, RPL19, GAPDH and B2M were used as reference genes. We report SERPINA3 to be strongly up-regulated in the brain of all human prion diseases, with only a mild up-regulation in AD. We show that this striking up-regulation, both at the mRNA and at the protein level, is present in all types of human prion diseases analyzed, although to a different extent for each specific disorder. Our data suggest that SERPINA3 may be involved in the pathogenesis and the progression of prion diseases, representing a valid tool for distinguishing different forms of these disorders in humans.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The prion diseases.J Geriatr Psychiatry Neurol. 2010 Dec;23(4):277-98. doi: 10.1177/0891988710383576. Epub 2010 Oct 11. J Geriatr Psychiatry Neurol. 2010. PMID: 20938044 Review.
-
[Familial prion disease (GSS, familial CJD, FFI)].Nihon Rinsho. 2007 Aug;65(8):1433-7. Nihon Rinsho. 2007. PMID: 17695280 Review. Japanese.
-
[Genetic background of human prion diseases].Ideggyogy Sz. 2007 Nov 30;60(11-12):438-46. Ideggyogy Sz. 2007. PMID: 18198790 Review. Hungarian.
-
An overview of human prion diseases.Virol J. 2011 Dec 24;8:559. doi: 10.1186/1743-422X-8-559. Virol J. 2011. PMID: 22196171 Free PMC article. Review.
-
Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.Neurosci Bull. 2021 Nov;37(11):1570-1582. doi: 10.1007/s12264-021-00764-y. Epub 2021 Sep 6. Neurosci Bull. 2021. PMID: 34487324 Free PMC article.
Cited by
-
Serpin Signatures in Prion and Alzheimer's Diseases.Mol Neurobiol. 2022 Jun;59(6):3778-3799. doi: 10.1007/s12035-022-02817-3. Epub 2022 Apr 13. Mol Neurobiol. 2022. PMID: 35416570 Free PMC article.
-
Gene expression and epigenetic markers of prion diseases.Cell Tissue Res. 2023 Apr;392(1):285-294. doi: 10.1007/s00441-022-03603-2. Epub 2022 Mar 21. Cell Tissue Res. 2023. PMID: 35307791 Free PMC article. Review.
-
Comprehensive Profiling of Gene Expression in the Cerebral Cortex and Striatum of BTBRTF/ArtRbrc Mice Compared to C57BL/6J Mice.Front Cell Neurosci. 2020 Dec 10;14:595607. doi: 10.3389/fncel.2020.595607. eCollection 2020. Front Cell Neurosci. 2020. PMID: 33362469 Free PMC article.
-
The Accumulation of Tau-Immunoreactive Hippocampal Granules and Corpora Amylacea Implicates Reactive Glia in Tau Pathogenesis during Aging.iScience. 2020 Jul 24;23(7):101255. doi: 10.1016/j.isci.2020.101255. Epub 2020 Jun 10. iScience. 2020. PMID: 32585593 Free PMC article.
-
Target Genes of Autism Risk Loci in Brain Frontal Cortex.Front Genet. 2019 Aug 9;10:707. doi: 10.3389/fgene.2019.00707. eCollection 2019. Front Genet. 2019. PMID: 31447881 Free PMC article.
References
-
- Collee JG, Bradley R, Liberski PP. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: part 2. Folia Neuropathol. 2006;44:102–110. - PubMed
-
- Advisory Committee on Dangerous Pathogens TSE Risk Assessment Subgroup (August 2016). “Appendix-III” position statement. Available from: ACDP TSE subgroup minutes, agendas and papers, https://app.box.com/s/hhhhg857fjpu2bnxhv6e (2016).
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous